Christina Kay - Nov 3, 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Christina Kay
Stock symbol
INBP
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/3/2021, 06:25 PM
Next filing
Nov 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +65K $0.00 65K Nov 3, 2021 Common Stock 65K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission.
F2 The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022.